Overview

An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Safety Follow-Up Trial to PDC-INS-0008 and MKC-TI-005
Phase:
Phase 2
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc